- The trend backdrop is active with a 9-week active streak.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Next-week expectancy is positive at 60.88% based on similar historical setup states.
SBRA
NASDAQ
Week ended 18 Sep 2026
Weekly Investor Report
Sabra Healthcare REIT Inc · Real Estate · Reit - Healthcare Facilities
Latest close
19.74 USD
-3.8%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -1.5% below the Trend Line and sits at 55.3% of its 52-week range. The latest completed week returned -3.8%, after a -3.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is mixed with 32/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 45d.
Setup score
52
out of 100
Latest Close
19.74 USD
18 Sep 2026
1W Return
-3.8%
latest completed week
4W Return
-3.2%
short-term follow-through
12W Return
1.0%
quarterly tape
Trend Breadth
86.5%
45 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- 4 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.8%
Latest completed week; four-week move -3.2%.
Indicator stack
79/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 60.88%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Mixed
32/100 conviction; expected move 2.5%.
News sentiment
49/100
21 relevant articles in the latest sentiment read.
Event risk
45d
Next report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -1.5% below the Trend Line and sits at 55.3% of its 52-week range. The latest completed week returned -3.8%, after a -3.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7112-week average 0.66
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.71Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.2% over four weeks, 1.0% over 12 weeks, and 10.4% over one year. The current trend has remained active for 9 consecutive weeks.
Performance by holding period
Active trend streak9 weeks
Active weeks in one year45
Trend breadth86.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.15Latest activity-pressure read.
Pressure change-8.8%Four-week change in activity pressure.
Leadership-7.97Latest relative-leadership reading.
RS change-74.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.
Factor week 11 Sep 2026
Financial statements through 30 Jun 2026
Field coverage 100%
Model confidence 100%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength35/100Blend of value, momentum, and quality. Underlying universe rank 66; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum69/100Medium-term price momentum. Underlying universe rank 32; rank 1 is best.
Growth13/100Revenue and earnings growth. Underlying universe rank 88; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 80.1x Price divided by trailing earnings.
- Price / sales
- 6.1x Market value relative to trailing revenue.
- EV / EBITDA
- 20.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 72.6% Gross profit retained from each unit of revenue.
- Operating margin
- 11.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 40.3% Free cash flow generated from revenue.
- Return on invested capital
- 1.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 17.3% Latest one-year revenue growth.
- EPS growth
- -64.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 2.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 5.8% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 5.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 6.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningMixed
SBRA shows mixed options pressure with a 32/100 conviction score, put-call volume ratio of 1.06, expected move of 2.5%, and Sharemaestro trend signal active.
Conviction32/100
Expected move2.5%
Put/call volume1.06
Insider activity18 / 2
18 acquisitions and 2 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment49/100
Weighted news tone is neutral across 21 relevant articles.
5 positive · 9 neutral · 7 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings45dNext report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
Options expected move2.5%Nearest-chain priced movement where available.
52-week drawdown-12.0%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Mar
24 Apr
22 May
19 Jun
17 Jul
14 Aug
18 Sep
Weeks higher16 of 2610 weeks finished lower.
Best week+11.2%Week of 24 Jul.
Worst week-7.2%Week of 5 Jun.
Latest week-3.8%Week of 18 Sep.
Shape of recent returns
Strong gains2
Modest gains14
Flat weeks0
Modest losses6
Sharp losses4
Recent vol4.5%13-week weekly-return volatility.
Base vol3.3%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Real Estate
4-week rank21 / 100
Group average-6.4%
Trend breadth40.0%
Trend40.0%active weekly trend signals
MD23.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryUS Reit - Healthcare Facilities
4-week rank4 / 15
Group average-4.4%
Trend breadth46.7%
Trend46.7%active weekly trend signals
MD20.0%positive activity pressure
RS26.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis49/100Latest 12-week confirmation: trend 9/12, activity pressure 8/12, relative leadership 2/12.
Activity pressure 0.71; 4 reversal markers Next-Week ExpectancyPositive 60.88%Next-week expectancy is positive with a 60.88% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors47/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 61; Small Cap Core rank 82 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options55/100SBRA shows mixed options pressure with a 32/100 conviction score, put-call volume ratio of 1.06, expected move of 2.5%, and Sharemaestro trend signal active.
Mixed · Options-market disagreement · Expected move 2.5% Sentiment49/100Weighted news tone is neutral across 21 relevant articles.
Sabra Healthcare REIT (NASDAQ:SBRA) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell? Insiders18 / 218 acquisitions and 2 disposals in the latest 180-day insider tape.
Earnings45dNext report is scheduled for 04 Nov 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 18 Sep 2026 | 19.74 USD | -3.8% | 20.04 USD | 16.16 USD | 0.15 | -7.97 | 14.4M | On |
| 11 Sep 2026 | 20.52 USD | -1.3% | 20.04 USD | 16.10 USD | 0.16 | -3.61 | 10.5M | On |
| 4 Sep 2026 | 20.78 USD | 0.8% | 20.02 USD | 16.04 USD | 0.08 | -3.10 | 10.5M | On |
| 28 Aug 2026 | 20.61 USD | 1.1% | 19.94 USD | 15.98 USD | 0.12 | -3.72 | 6.8M | On |
| 21 Aug 2026 | 20.39 USD | 0.3% | 19.86 USD | 15.91 USD | 0.17 | -4.56 | 12.1M | On |
| 14 Aug 2026 | 20.32 USD | -2.0% | 19.79 USD | 15.85 USD | 0.40 | -7.43 | 12.0M | On |
| 7 Aug 2026 | 20.73 USD | -0.6% | 19.73 USD | 15.78 USD | 0.31 | -4.67 | 16.7M | On |
| 31 Jul 2026 | 20.86 USD | -5.3% | 19.67 USD | 15.71 USD | 0.03 | 0.67 | 11.5M | On |
| 24 Jul 2026 | 22.03 USD | 11.2% | 19.59 USD | 15.64 USD | -0.09 | 6.86 | 20.9M | On |
| 17 Jul 2026 | 19.82 USD | 2.5% | 19.47 USD | 15.57 USD | -0.41 | -5.32 | 15.2M | Off |
| 10 Jul 2026 | 19.33 USD | -4.1% | 19.41 USD | 15.51 USD | -0.56 | -11.58 | 12.6M | Off |
| 3 Jul 2026 | 20.16 USD | 3.2% | 19.39 USD | 15.45 USD | -0.64 | -6.42 | 12.2M | Off |
| 26 Jun 2026 | 19.54 USD | 7.8% | 19.34 USD | 15.38 USD | -0.79 | -8.71 | 24.6M | Off |
| 19 Jun 2026 | 18.12 USD | -3.3% | 19.32 USD | 15.32 USD | -0.92 | -19.34 | 16.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.